Playboy Converts Remaining Preferred Shares to Common Stock at Over $1.74 Per Share Company Continues to Improve Balance Sheet GlobeNewswire August 25, 2025 LOS ANGELES, Aug. 25, 2025 (GLOBE NEWSWIRE) — Playboy, Inc. (NASDAQ: PLBY) (the “Company” or “Playboy”), one of the most recognizable and iconic brands in the world, today announced that it converted […]

Bright Minds Biosciences to Present at Upcoming Conferences GlobeNewswire August 25, 2025 NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) — Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS)

Beyond Oil Announces Conditional Approval of Uplisting to the Toronto Stock Exchange GlobeNewswire August 25, 2025 VANCOUVER, British Columbia and KIBBUTZ YIFAT, Israel, Aug. 25, 2025 (GLOBE NEWSWIRE) — Beyond Oil Ltd. (CSE:BOIL) (OTCQB:BEOLF) (“Beyond Oil” or the “Company“), a food-tech innovation company dedicated to reducing health risks associated with fried food while lowering operational

Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib GlobeNewswire August 25, 2025 – Immuneering to evaluate atebimetinib in combination with olomorasib in planned Phase 2 trial in patients with advanced non-small cell lung cancer – CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage

4DMT to Participate in Upcoming Investor Conferences GlobeNewswire August 25, 2025 EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will

Fate Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire August 25, 2025 SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, announced that the Company will participate in the following

James Altucher Issues New Trillion-Dollar Prediction Centered on Elon Musk's “AI Mothership” A newly surfaced presentation unveils Altucher's latest warning — a call that places Musk at the center of the next great wave of artificial superintelligence. GlobeNewswire August 25, 2025 Washington, D.C., Aug. 25, 2025 (GLOBE NEWSWIRE) — In a newly released presentation, bestselling

Highway Launches the Trusted Freight Exchange, Powered by the Triumph Network The Industry's First Secure Digital Freight Exchange for Verified Freight GlobeNewswire August 25, 2025 DALLAS, Aug. 25, 2025 (GLOBE NEWSWIRE) — Highway, the leader in Carrier Identity(R) and compliance solutions, today announced the official launch of the Trusted Freight Exchange (TFX), the first secure

Sow Good to Present at the 2025 Gateway Conference on September 4th GlobeNewswire August 25, 2025 IRVING, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) — Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, is confirmed to present at the 2025 Annual Gateway Conference, which

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference GlobeNewswire August 25, 2025 SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September